HeyJaredDeep Dive In Vitiligo
Explore the powerful story of vitiligo—a ‘white armor’ that challenges, empowers, and inspires resilience.Join us weekly as we delve into the science, medicine, philosophy, and personal experiences behind this intricate skin condition.Hosted by Yan Valle, CEO of the VR…
- Indexed episodes, last 90 days
- 13
- Latest publication
- Sep 21, 2026
- Audience
- Checking…
- Earliest in this view
- Jul 6, 2026
Latest episodes
Searching to Surrender: Don’t Let AI Out of the Fire Pit (Ep. 78) (opens the original)
Read excerpt
Fifteen years ago, keeping up with vitiligo news was easy. There simply wasn’t that much of it. Today, research, clinical trials, industry updates, patient discussions, and AI-generated answers arrive faster than anyone can realistically process them. In Episode 78 of Deep Dive in Vitiligo, we look at what happens next: people stop searching, comparing, and opening twenty browser tabs — and start asking AI to do the thinking for them. That shift has a name: cognitive surrender. We explore why ha
Vitiligo in Uniform — Same Disease, Different System (ep. 77) (opens the original)
Read excerpt
What changes when vitiligo puts on a uniform? The disease stays the same. Almost everything around it changes — from medical fitness and deployment to treatment access, military records, VA care, and disability claims. In this episode of Deep Dive in Vitiligo, we follow the patient journey from sick call to civilian care and examine where people, records, and responsibility can fall through the cracks. We also separate three questions that are too often mixed together: Can someone join? Can they
Dos ensayos de ruxolitinib en niños con vitiligo. Misma crema. Distinto mapa (Ep. 76) (opens the original)
Read excerpt
Durante años, la crema aprobada se detenía a los 12. Los más pequeños se quedaban con el menú de siempre: corticoides, tacrolimus, luz si había hueco, y mucha espera. Eso empieza a cambiar. Hay dos ensayos de fase 3 con crema de ruxolitinib — Opzelura, si ya conoces el tubo — en niños con la forma más común de vitíligo. Protocolos de verdad. Centros de verdad. No un rumor de un grupo de padres. El matiz: no son el mismo estudio. Si los mezclas, una familia reserva viaje al continente equivocado.
Two Pediatric Vitiligo Trials. Same Cream. Different Continents (Ep. 75) (opens the original)
Read excerpt
For years, approved ruxolitinib cream has stopped at age 12. Younger children have had a much shorter menu: steroids, tacrolimus, light therapy if you can get a slot, and a lot of waiting. Now two Phase III studies are evaluating ruxolitinib cream in younger children. Its use for vitiligo in these age groups is investigational — researchers are still finding out how well it works and how safe it is. Real protocols. Real sites. Not a rumor from a parent group. Then the catch: they are not the sam
Fit, Friction, and Flares: Finding the Right Glove for Hand Vitiligo (Ep. 74) (opens the original)
Read excerpt
Most people think gloves are simple: put them on, protect your hands, move on with life. Unfortunately, your skin didn’t get that memo. In this episode of Deep Dive in Vitiligo, we explore the surprisingly complicated world of work gloves, hand dermatitis, chemical leukoderma, and the Koebner phenomenon. Why do some gloves trigger itching, cracking, or irritation? Why can friction matter almost as much as chemicals? And why are many dermatologists quietly steering patients toward accelerator-fre
Publishing over time
Last 90 days. Choose a month to open its work.
Recurring subjects
Named in the text we hold. One piece can cover several.
Audience
No verified audience measurement yet.
About this data
Counts cover the work we have indexed. Tone needs enough text and a confident classification. Excerpts and episode notes are not full articles or transcripts.
Identity or attribution wrong? Suggest a correction.